Questions about XY Wen et al. entitled “Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis”

Tumor Biology

Volumn 36, Issue 2, 2015, Pages 557-558

  Liu, Fanxiao ^a   Zhang, Qingyu ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Matrix metalloproteinase 2; Meta analysis; Osteosarcoma

Indexed keywords

GELATINASE A;

ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; COHORT ANALYSIS; DATA EXTRACTION; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; INFORMATION PROCESSING; META ANALYSIS (TOPIC); MOLECULAR BIOLOGY; OSTEOSARCOMA; PRIORITY JOURNAL; BONE TUMOR; GENETICS; MORTALITY;

BONE NEOPLASMS; HUMANS; MATRIX METALLOPROTEINASE 2; OSTEOSARCOMA;

EID: 84925541920     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3173-0     Document Type: Article

References (6)

1. Wen X et al. Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis. Tumour Biol. 2014;35(1):845–8.
2. Guo HB, Xiao T. Letter regarding Wen X.Y. et al. entitled "Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis". Tumour Biol. 2014;35(5):5053.
3. Kushlinsky NE, Solovyov YN, Babkina IV, Gershtein ES, Bulicheva IV. Matrix metalloproteinases 2,7, and tissue inhibitor of matrix metalloproteinase-1 in the sera of patients with bone tumors. Bull Exp Biol Med. 2010;149:233–5.
4. Sun C, Zang Y, Yang L, Liu H, Li S. Association of malignant osteoblastoma prognosis with midkine, survivin and MMP-2 expression [article in Chinese]. Med Recapitulate. 2010;16:3833–4.
5. Uchibori M, Nishida Y, Nagasaka T, Yamada Y, Nakanishi K, Ishiguro N. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma. Int J Oncol. 2006;28:33–42.
6. Li W, Ye Z, Yang D, Tao H. The expression of vascular endothelial growth factor, matrix metalloproteinases 2,9 in osteosarcoma [article in Chinese]. Zhejiang Med J. 2006;28:691–4.